Nichi-Iko Of Japan To Buy Major Stake In Aprogen Of S. Korea
This article was originally published in PharmAsia News
Executive SummaryJapan's Nichi-Iko Pharmaceutical is buying a third of South Korea's Aprogen to gain the start-up's bioengineered drugs to sell in the Japanese market
You may also be interested in...
Amneal has acquired a majority stake in manufacturer and wholesaler AvKARE, giving the firm access to the “large, complex and growing federal healthcare market.”
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
Execs On The Move: Owens & Minor And MicroPort See Big Departures; Dynatronics CEO Moving To BrainsWay
Owens & Minor finance boss joins drug-delivery device maker Intersect ENT; operations VP at MicroPort joins bioprosthetic heart maker Carmat; Dynatronics CEO will head neuromodulation product firm BrainsWay in January; and more.